Bruce L. A. Carter, Director at ENANTA PHARMACEUTICALS INC (ENTA), sold 11,693 shares at $66.70 ($793K) on 2022-03-21, disclosed to the SEC on 2022-03-22.
Open-market sale of $793k ENTA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.70 | 2,676 | $178K | 22.5% |
| 2 | $66.70 | 2,676 | $178K | 22.5% |
| 3 | $67.23 | 307 | $21K | 2.6% |
| 4 | $68.66 | 2,210 | $152K | 19.1% |
| 5 | $68.66 | 2,210 | $152K | 19.1% |
| 6 | $69.52 | 807 |
| $56K |
| 7.1% |
| 7 | $69.52 | 807 | $56K | 7.1% |
| Total | $67.84 avg | 11,693 | $793K | 100% |
| Filing → |
| MRTX | SELL | 2021-02-03 | $430K | — | Filing → |
| MRTX | SELL | 2020-12-16 | $1.1M | — | Filing → |
| MRTX | SELL | 2020-08-13 | $378K | — | Filing → |